The Female Founders of MicroVentures’ Portfolio
Amidst male dominance, female founders thrive, with nearly 13M women-owned businesses in the U.S. carving their entrepreneurial paths
Humans 2.0: Upgrading Our Biology to Fight Disease
One founder’s mission to upgrade human biology and equip us with a new weapon against disease.
Rebel Elements — The 10 New Investments From RebelBio
RebelBio, SOSV’s London program, backs 10 science startups for pioneering breakthroughs. Read more on our latest cohort.
Hikma Ventures Invests in Biotechnology Company BioSapien Inc.
Hikma Ventures invests in BioSapien’s MediChip®, a revolutionary 3D-printed technology for targeted cancer drug delivery, transforming chemotherapy.
BioSapien Closes $1.8M Seed Round Led By SOSV & HIKMA Ventures
BioSapien secures $1.8M seed led by SOSV & Hikma Ventures for MediChip™: 3D printed mesh delivering cancer drugs with fewer side effects.
MediChip Aims to Deliver Localized Cancer Treatment
BioSapien’s MediChip: 3D-printed mesh delivers chemo directly to tumors, bypassing systemic side effects. Revolutionizing cancer treatment.
Vosfox Welcomes BioSapien as our Customer
Exciting news: Vosfox Medical partners with Biosapien, introducing MediChip, a 3D-printed drug-delivery mesh for cancer treatment.
Khatija Ali is the CEO & Founder of BioSapien
Khatija Ali, CEO of BioSapien, innovates patient care with MediChip®. NSF grant recipient & fundraiser, passionate educator, and philanthropist.
